NCT01598298

Clinical Trial Information


Trial Number: NCT01598298 (ClinicalTrials.gov)
Disease Type:
  • Breast Neoplasm - Miscellaneous
Trial Title:
A Randomized Placebo-Controlled Phase III Study of Duloxetine for Treatment of Aromatase Inhibitor-Associated Musculoskeletal Symptoms in Women With Early Stage Breast Cancer
Study ID:
S1202
Images are available?:
No
Is this a NCI-MATCH Trial?:
No


Datasets Linked to Trial

Title Description
NCT01598298-D3 This dataset will allow users to reproduce the results reported in the Journal of Clinical Oncology (Henry et al., JCO, 2017), which contains patient-level data (one row per patient), including eligibility, evaluability, treatment, demographic, and baseline information.
NCT01598298-D2 This dataset will allow users to reproduce the results reported in the Journal of Clinical Oncology (Henry et al., JCO, 2017), which contains event-level information (one row per patient per adverse event experienced on trial).
NCT01598298-D1 This dataset will allow users to reproduce the results reported in the Journal of Clinical Oncology (Henry et al., JCO, 2017), which contains assessment-level data (one row per patient per planned assessment time), including scores for each of the patient-completed questionnaires, days from registration to time of assessment, and whether the questionnaires were completed within the protocol-mandated time frame.